HCM
ABEO icon

Highlander Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Highlander Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$7 Hold
1
– – ﹤0.01% 944
2023
Q4 		$5 Hold
1
– – ﹤0.01% 980
2023
Q3 		$0 Buy
+1
New +$4 ﹤0.01% 902
2019
Q3 		– Sell
-1
Closed – – 657
2019
Q2 		$0 Hold
1
– – ﹤0.01% 681
2019
Q1 		$0 Buy
+1
New +$179 ﹤0.01% 685

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Highlander Capital Management's ABEO Position: Q1 2024 in Review

Highlander Capital Management held its Abeona Therapeutics (ABEO) position steady in Q1 2024 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Highlander Capital Management first reported a position in ABEO in Q1 2019 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold ABEO as of Q1 2024.

  • Highlander Capital Management held 1 share of Abeona Therapeutics worth $7 as of Q1 2024.
  • Highlander Capital Management left its Abeona Therapeutics share count unchanged in Q1 2024.
  • Abeona Therapeutics made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #944 holding.
  • Highlander Capital Management first reported a position in Abeona Therapeutics in Q1 2019 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.